Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Administrative data

Description of key information

Key value for chemical safety assessment

Skin sensitisation

Link to relevant study records
Reference
Endpoint:
skin sensitisation: in vivo (non-LLNA)
Type of information:
experimental study
Adequacy of study:
key study
Reliability:
1 (reliable without restriction)
Rationale for reliability incl. deficiencies:
other: Study conducted per OECD Test Guideline 406 and EPA OPPTS 870.2600 following GLP.
Qualifier:
according to guideline
Guideline:
OECD Guideline 406 (Skin Sensitisation)
Qualifier:
according to guideline
Guideline:
EPA OPPTS 870.2600 (Skin Sensitisation)
GLP compliance:
yes
Remarks:
US EPA GLPs (40 CFR, Part 792) and OECD GLPs
Type of study:
Buehler test
Species:
guinea pig
Strain:
Hartley
Sex:
male/female
Details on test animals and environmental conditions:
Male and female albino Hartley guinea pigs were received from Elm Hill Breeding Labs, Inc. They were 373.6-437.8 g and at least 21 days of age. They were group-housed upon arrival in stainless steel suspended cages. The animals were acclimated for at least 5 days prior to dosing. Water and feed were provided ad libitum. The temperature during the test period was 68 +/- 5 degrees F with a relative humidity range of 30-70%. Room lights were on a 12-hour light/dark cycle.
Route:
epicutaneous, occlusive
Vehicle:
other: 80% Ethanol (induction phase) or Acetone (challenge phase)
Concentration / amount:
0.4 g
Route:
epicutaneous, occlusive
Vehicle:
other: 80% Ethanol (induction phase) or Acetone (challenge phase)
Concentration / amount:
0.4 g
No. of animals per dose:
Experimental – 10/sex
Negative Controls – 5/sex
Positive Controls – 3 males and 2 females
Preliminary Irritation – 1 male and 2 females
Details on study design:
Before each application of the test or control substance, the animals were clipped and shaved or depilitated on the scapula region in an area of about 3 cm x 4 cm.

A preliminary irritancy test was conducted, in which it was determined that 0.4 g PCP moistened with 80% Ethanol was the highest non-irritating concentration.

For the main study, for the induction phase, closed patches for the experimental group were prepared with the PCP moistened with 80% Ethanol and were applied directly to the skin and covered with a gauze pad of approximately 4-6 cm². The patch was kept in place with occlusive bandaging. The patch was removed after 6 hours of exposure and any residual PCP was wiped off with a gauze pad. The test substance was applied once per week for 3 consecutive weeks (Days 0, 7 and 14) on one side of the animal. The positive control substance (dinitrochlorobenzene, DNCB) was applied in the same manner. Naive animals, i.e., untreated during the induction phase, served as a negative control group.

On the day of the challenge, a 4 x 3 cm virgin skin site was shaved on the flanks of the experimental and control animals. The challenge test was performed in the same way as the 6-hour closed patch test of the induction phase. The skin was exposed to PCP for 6 hours. The concentration used at challenge was the highest non–irritating dose determined in the Preliminary Irritation Study. At approximately 21 hours after removal of the challenge dose, the area of the challenge was marked and the whole back shaved. Approximately three hours after shaving, the test site was examined for erythema and edema. The reaction was graded according to the Magnusson and Kligman Grading Scale for the Evaluation of Challenge Patch Test Reactions. Reading of the skin area was repeated at approximately 48 hours after removal of the challenge dose and the skin reactions were graded.

0 = No reactions
1 = discrete or patchy erythema
2 = moderate and confluent erythema
3 = intense erythema and swelling
Challenge controls:
Negative Controls – 5 per sex
Positive Controls – 3 males and 2 females
Positive control substance(s):
yes
Remarks:
Dinitrochlorobenzene (DNCB)
Positive control results:
Following the challenge application of 0.1% DNCB to the test animals, 5 of 5 animals developed moderate to intense erythema and edema within 24 hours. All animals continued to exhibit discrete to moderate erythema and discrete to intense edema through 48 hours.
Reading:
1st reading
Hours after challenge:
24
Group:
test chemical
Dose level:
0.4 g
No. with + reactions:
0
Total no. in group:
20
Clinical observations:
none
Remarks on result:
other: Reading: 1st reading. . Hours after challenge: 24.0. Group: test group. Dose level: 0.4 g. No with. + reactions: 0.0. Total no. in groups: 20.0. Clinical observations: none.
Reading:
2nd reading
Hours after challenge:
48
Group:
test chemical
Dose level:
0.4 g
No. with + reactions:
0
Total no. in group:
20
Clinical observations:
none
Remarks on result:
other: Reading: 2nd reading. . Hours after challenge: 48.0. Group: test group. Dose level: 0.4 g. No with. + reactions: 0.0. Total no. in groups: 20.0. Clinical observations: none.
Reading:
1st reading
Hours after challenge:
24
Group:
negative control
Dose level:
0 g
No. with + reactions:
0
Total no. in group:
10
Clinical observations:
none
Remarks on result:
other: Reading: 1st reading. . Hours after challenge: 24.0. Group: negative control. Dose level: 0 g. No with. + reactions: 0.0. Total no. in groups: 10.0. Clinical observations: none.
Reading:
2nd reading
Hours after challenge:
48
Group:
negative control
Dose level:
0 g
No. with + reactions:
0
Total no. in group:
10
Clinical observations:
none
Remarks on result:
other: Reading: 2nd reading. . Hours after challenge: 48.0. Group: negative control. Dose level: 0 g. No with. + reactions: 0.0. Total no. in groups: 10.0. Clinical observations: none.
Reading:
1st reading
Hours after challenge:
24
Group:
positive control
Dose level:
0.1%
No. with + reactions:
5
Total no. in group:
5
Clinical observations:
none
Remarks on result:
other: Reading: 1st reading. . Hours after challenge: 24.0. Group: positive control. Dose level: 0.1%. No with. + reactions: 5.0. Total no. in groups: 5.0. Clinical observations: none.
Reading:
2nd reading
Hours after challenge:
48
Group:
positive control
Dose level:
0.1%
No. with + reactions:
5
Total no. in group:
5
Clinical observations:
none
Remarks on result:
other: Reading: 2nd reading. . Hours after challenge: 48.0. Group: positive control. Dose level: 0.1%. No with. + reactions: 5.0. Total no. in groups: 5.0. Clinical observations: none.
Interpretation of results:
not sensitising
Remarks:
Migrated information Criteria used for interpretation of results: EU
Conclusions:
Under the conditions of this study, PCP was not a skin sensitizer.
Endpoint conclusion
Endpoint conclusion:
no adverse effect observed (not sensitising)
Additional information:

The skin sensitisation potential was investigated in a study performed per OECD Test Guideline 406 and EPA OPPTS 870.2600 under GLP conditions (Toxikon Corporation, 2002).

Male and female albino Hartley guinea pigs were exposed to the test substance in 80 % Ethanol (induction phase) or Acetone (challenge phase) during a Buehler test.

Under the conditions of this study, PCP was not a skin sensitiser.


Migrated from Short description of key information:
In a skin sensitisation study performed per OECD Test Guideline 406 and EPA OPPTS 870.2600 the substance was non-sensitising in the guinea pig.

Justification for selection of skin sensitisation endpoint:
Only one study available.

Respiratory sensitisation

Endpoint conclusion
Endpoint conclusion:
no study available

Justification for classification or non-classification

In accordance with the criteria for classification as defined in Annex I, Regulation (EC) No 1272/2008, the substance does not require classification with respect to skin sensitisation.